Also available in: Español
Rev Mex Urol. 2018 November-December;78(6):414-18 DOI: https://doi.org/10.24245/revmexurol.v78i6.2223
Maricela Martínez-Montoya,1 Miguel Ángel Hernández-Farías,2 Jorge Jaspersen-Gastelum,3 Francisco Virgen-Gutiérrez,3 Alejandro Rosas-Ramírez,3 Jorge Jaspersen-Álvarez,4 Luis Daniel Carillo-Córdova5
1 Nutrition Science, Universidad del Valle de Toluca, Estado de México.
2 Urology Residency.
3 Urology Service.
4 Pregraduate Medical Intern.
5 Urology Graduate.
Hospital General de México Dr. Eduardo Liceaga, Mexico City.
BACKGROUND: Urolithiasis and metabolic syndrome are considered a worldwide pandemic, with important health system repercussions. Mexico has a high incidence of both pathologies. Identifying the predisposing factors of urolithiasis will prevent recurrence, complications, and surgical treatments.
OBJECTIVE: To establish the prevalence of metabolic syndrome and evaluate the modifications in urolithiasis pathophysiology.
MATERIALS AND METHODS: A non-randomized cross-sectional study was conducted on patients seen at the Hospital General de México Dr. Eduardo Liceaga, diagnosed with urolithiasis within the time frame of March to December 2016. Study variables: anthropometric measurements, blood pressure readings, and fasting glucose levels and lipid profiles.
RESULTS: Eighty-four patients, 32 men and 52 women, were enrolled in the study. Their mean age was 47.3 ± 14.1 years. A total of 52% of the cases of urolithiasis corresponded to women. Metabolic syndrome was diagnosed in 58 of the study patients, 29% of whom were men and 71% women, representing a woman:man prevalence ratio of 3:1.
CONCLUSIONS: Urolithiasis should not be considered an isolated entity, but rather understood in a multifactorial context and as a systemic disease.
KEYWORDS: Metabolic syndrome; Obesity; Urolithiasis.
Miguel Ángel Hernández Farías